ジャーナル: iScience / 年: 2022 タイトル: Potent and broad neutralization of SARS-CoV-2 variants of concern (VOCs) including omicron sub-lineages BA.1 and BA.2 by biparatopic human VH domains. 著者: Chuan Chen / James W Saville / Michelle M Marti / Alexandra Schäfer / Mary Hongying Cheng / Dhiraj Mannar / Xing Zhu / Alison M Berezuk / Anupam Banerjee / Michele D Sobolewski / Andrew Kim ...著者: Chuan Chen / James W Saville / Michelle M Marti / Alexandra Schäfer / Mary Hongying Cheng / Dhiraj Mannar / Xing Zhu / Alison M Berezuk / Anupam Banerjee / Michele D Sobolewski / Andrew Kim / Benjamin R Treat / Priscila Mayrelle Da Silva Castanha / Nathan Enick / Kevin D McCormick / Xianglei Liu / Cynthia Adams / Margaret Grace Hines / Zehua Sun / Weizao Chen / Jana L Jacobs / Simon M Barratt-Boyes / John W Mellors / Ralph S Baric / Ivet Bahar / Dimiter S Dimitrov / Sriram Subramaniam / David R Martinez / Wei Li / 要旨: The emergence of SARS-CoV-2 variants of concern (VOCs) requires the development of next-generation biologics with high neutralization breadth. Here, we characterized a human V domain, F6, which we ...The emergence of SARS-CoV-2 variants of concern (VOCs) requires the development of next-generation biologics with high neutralization breadth. Here, we characterized a human V domain, F6, which we generated by sequentially panning large phage-displayed V libraries against receptor binding domains (RBDs) containing VOC mutations. Cryo-EM analyses reveal that F6 has a unique binding mode that spans a broad surface of the RBD and involves the antibody framework region. Attachment of an Fc region to a fusion of F6 and ab8, a previously characterized V domain, resulted in a construct (F6-ab8-Fc) that broadly and potently neutralized VOCs including Omicron. Additionally, prophylactic treatment using F6-ab8-Fc reduced live Beta (B.1.351) variant viral titers in the lungs of a mouse model. Our results provide a new potential therapeutic against SARS-CoV-2 variants including Omicron and highlight a vulnerable epitope within the spike that may be exploited to achieve broad protection against circulating variants.